Pharmacy News Article

GE Healthcare, a unit of General Electric Company (NYSE: GE), announces the global launch of the first biomolecular imaging systems developed as part of its strategic alliance with FUJIFILM. The announcement comes just five months after signing the alliance agreement (see also Life Sciences).

The four systems being launched comprise two laser scanning and two CCD camera based imagers, which together address a wide range of radioisotopic, fluorescent and chemiluminescent imaging applications in the life sciences arena. In combination with proprietary Amersham ECL reagents, CyDye chemistries and image analysis software products, GE Healthcare can provide extensive imaging solutions to life scientists to support differing levels of assay complexity and budget.

The versatile imagers, which are the Typhoon FLA 9000, Typhoon FLA 7000, ImageQuant LAS 4000, and the ImageQuant LAS 4000 mini, are designed to support a wide range of applications out of the box, with the flexibility to adapt to future applications. GE's global service and support network will be available to provide cover for all imagers sold under the GE brand.

"We aim to provide scientists with comprehensive system solutions for research, drug discovery and bioanalytical applications," said Nigel Darby , General Manager Bio Technologies, GE Healthcare, "Furthermore, the integration of the imaging platforms with our global service organization gives valuable support."

For more information about the full range of biomolecular imagers available from GE Healthcare please visit www.gelifesciences.com/quantitative-imaging.

- ENDS -

ABOUT GE HEALTHCARE:

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

Contact

College Hill

Lynne Trowbridge, Katie Odgaard, Cosima Toepfer

+44 (0)20 7866 7861

ge-proteins@collegehill.com